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Abstract
Background:  Heat shock factor (HSF/HSF1) not only is the transcription factor primarily
responsible for the transcriptional response of cells to physical and chemical stress but also
coregulates other important signaling pathways. The factor mediates the stress-induced expression
of heat shock or stress proteins (HSPs). HSF/HSF1 is inactive in unstressed cells and is activated
during stress. Activation is accompanied by hyperphosphorylation of the factor. The regulatory
importance of this phosphorylation has remained incompletely understood. Several previous
studies on human HSF1 were concerned with phosphorylation on Ser303, Ser307 and Ser363, which
phosphorylation appears to be related to factor deactivation subsequent to stress, and one study
reported stress-induced phosphorylation of Ser230 contributing to factor activation. However, no
previous study attempted to fully describe the phosphorylation status of an HSF/HSF1 in stressed
cells and to systematically identify phosphoresidues involved in factor activation. The present study
reports such an analysis for human HSF1 in heat-stressed cells.
Results: An alanine scan of all Ser, Thr and Tyr residues of human HSF1 was carried out using a
validated transactivation assay, and residues phosphorylated in HSF1 were identified by mass
spectrometry and sequencing. HSF1 activated by heat treatment was phosphorylated on Ser121,
Ser230, Ser292, Ser303, Ser307, Ser314, Ser319, Ser326, Ser344, Ser363, Ser419, and Ser444. Phosphorylation
of Ser326 but none of the other Ser residues was found to contribute significantly to activation of
the factor by heat stress. Phosphorylation on Ser326 increased rapidly during heat stress as shown
by experiments using a pSer326 phosphopeptide antibody. Heat stress-induced DNA binding and
nuclear translocation of a S326A substitution mutant was not impaired in HSF1-negative cells, but
the mutant stimulated HSP70 expression several times less well than wild type factor.
Conclusion:  Twelve Ser residues but no Thr or Tyr residues were identified that were
phosphorylated in heat-activated HSF1. Mutagenesis experiments and functional studies suggested
that phosphorylation of HSF1 residue Ser326 plays a critical role in the induction of the factor's
transcriptional competence by heat stress. PhosphoSer326 also contributes to activation of HSF1 by
chemical stress. To date, no functional role could be ascribed to any of the other newly identified
phosphoSer residues.
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Background
Phosphorylation emerged as a major post-translational
mechanism that is well suited for effecting a rapid change
in the activity of a transcription factor in response to an
extracellular signal [1,2]. During periods of physical or
chemical stress, transcription of genes encoding cytopro-
tective heat shock or stress proteins (HSPs) is increased.
This enhanced expression is primarily mediated by heat
shock factor 1 (HSF1) in vertebrate cells or by a homolo-
gous factor (HSF) in non-vertebrate cells. HSF/HSF1 is
continuously present in cells but is only activated when
the cells experience a stress. It was long known that HSF/
HSF1 is hyperphosphorylated in stressed cells [3-5].
Activation of human HSF1 occurs in at least two steps. A
first step results in formation of factor homotrimers that
are capable of binding so-called heat shock element
(HSE) sequences present in hsp genes but essentially lack
transcriptional activity. In a second step, these HSF1
homotrimers are converted to a transcriptionally compe-
tent form [6-8]. In cells exposed to heat, acquisition of
HSE DNA-binding activity was observed to precede hyper-
phosphorylation of HSF1 [9]. This result suggested that
hyperphosphorylation could play a regulatory role in the
second activation step that renders the factor transactiva-
tion-competent. Several additional observations are com-
patible with the hypothesis that hyperphosphorylation of
HSF1 is required for or enhances induction of the tran-
scriptional competence of the factor: (i) To the extent this
was examined, all conditions that resulted in activation of
HSF1 also induced hyperphosphorylation of the factor.
(ii) Conversely, compounds such as salicylate, indometh-
acin, menadione and hydrogen peroxide that were only
capable of triggering the first step of HSF1 activation also
failed to prompt factor hyperphosphorylation [8,10,11].
(iii) Inhibitors of Ser/Thr protein kinases reduced, and
inhibitors of Ser/Thr phosphatases enhanced, HSF1 activ-
ity [11-17]. For the inhibitors investigated it was found
that they did not affect HSF1 DNA-binding activity [11]
(see also [18]).
To date, stress-induced phosphorylation of HSF/HSF1 has
not been comprehensively analyzed. However, phospho-
rylation of Ser230 of human HSF1 was reported to contrib-
ute to heat activation of the factor by enhancing its
transcriptional competence [19]. It was also proposed that
phosphorylation of Thr142 of human HSF1 may be essen-
tial for factor activity [20]. Furthermore, several HSF/HSF1
residues whose phosphorylation repressed factor activity
were identified [9,21-30]. In human HSF1 these residues
are Ser303, Ser307 and Ser363. The present study sought to
combine systematic mutagenesis and physical analyses to
provide a broad accounting of phosphorylation of HSF1
in heat-stressed cells.
Results
Validation of a transactivation assay for testing HSF1 
mutants
In chimeric transcription factor LEXA-(human)HSF1 the
DNA-binding domain (residues 1–78) of the 529-residue
human HSF1 polypeptide is substituted with that of bac-
terial repressor LEXA (residues 1–87) [7]. LEXA-HSF1 is
known from previous studies to be regulated similarly as
HSF1 [7]. Transactivation by LEXA-HSF1 was assessed by
dual luciferase assay of cells co-transfected with a firefly
luciferase gene responsive to LEXA-HSF1 (LEXA-fLUC)
and a constitutively expressed Renilla  luciferase gene
(pRL-TK or pRL-CMV). Reporter activity was expressed as
the ratio of firefly and Renilla luciferase activities. To per-
mit the identification of mutants of LEXA-HSF1 with only
minor functional impairments, the transactivation assay
needed to sensitively detect changes in transcription factor
activity. To find out whether the assay had this capability
under the chosen experimental conditions, 96-well cul-
tures were transfected with different amounts of expres-
sion construct LEXA-HSF1 (Figure 1A). At amounts below
about 2 ng/culture, reporter activity increased proportion-
ally with the amount of expression construct transfected.
Hence, at these low DNA concentrations changes in LEXA-
HSF1 activity were certain to be reflected in proportional
changes in reporter activity. Most subsequent transfec-
tions were carried out with 0.5 ng or less of expression
construct per 96-well culture. Transfection with 0.5 ng of
construct LEXA-HSF1 resulted in a 30% increase in total
HSF1 concentration as estimated by western blot one day
after transfection (Figure 1B). Assuming a typical transfec-
tion efficiency of 20–40%, this result implied that trans-
fected cells on average expressed comparable amounts of
LEXA-HSF1 and endogenous HSF1. Hence, under these
conditions, under which an exogenous HSF1 form was
not or was only minimally overexpressed, the regulatory
environment encountered by the exogenous HSF1 form
was likely to be similar to that to which endogenous factor
is exposed. This is a departure from several earlier studies
relating to HSF1 phosphorylation, including one from
our own group [28], in which studies exogenous HSF1
forms were substantially overexpressed. A known result of
such overexpression is that a significant fraction of exoge-
nous factor accumulates as DNA-binding trimers in the
absence of a stress [7]. At the low levels of expression con-
struct transfected in the assays used herein, this result did
not occur (as documented, e.g., by the experiment shown
in Figure 3A).
Alanine scan of LEXA-HSF1
Substitution mutants of LEXA-HSF1 or FLAG-LEXA-HSF1
(FLAG-tagged LEXA-HSF1) were prepared that collectively
covered all 92 Ser, Thr and Tyr residues of the HSF1
sequence present in LEXA-HSF1. Transactivation assays
were carried out to compare transcription-enhancingBMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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Validation of the transactivation assay used, transactivation analysis of mutant S326A, and isolation of FLAG-HSF1 for phospho- rylation analyses Figure 1
Validation of the transactivation assay used, transactivation analysis of mutant S326A, and isolation of FLAG-
HSF1 for phosphorylation analyses. (A) Transactivation assay of cells in 96-well dishes co-transfected with reporter gene 
mixture (LEXA-fLUC and pRL-CMV) and 0–40 ng LEXA-HSF1. C: Control unheated cells; HS: Cells subjected to standard 
heat-treatment for 30 min at 44°C. (B) Relative amounts of HSF1-immunoreactive protein in cells transfected with 0.5 ng β -
galactosidase expression construct (B-GAL) or 0.5 ng LEXA-HSF1. Extracts prepared one day after transfection were analyzed 
by anti-HSF1 western blot. A quantitation of the HSF1 signals, shown in the inserts on top, is presented. Note that the insert 
only shows the relevant (scanned) portion of the blot, i.e., polypeptide sizes from about 60–100 kD. HSF1 forms appear as sev-
eral closely spaced bands above a single band representing a nonspecific signal. (C) Coomassie Blue-stained gel containing 
immune-isolated FLAG-HSF1. M: markers having molecular weights in kD as indicated on the left. Note that the cluster of 
bands appearing at and below the 98 kD marker was identified as HSF1 forms by a parallel anti-HSF1 western blot (not shown). 
(D) Transactivation assay comparing activities of HSF1 forms in cells co-transfected with luciferase reporter gene mixture and 
expression constructs (0.5 ng) for FLAG-LEXA-HSF1 substitution mutant S326A, parent FLAG-LEXA-HSF1 or B-GAL. One 
day after transfection, cells were exposed either to 300 µM CdCl2 for 2 h (Cd) or to standard heat treatment (HS), or were 
left untreated (C). Relative firefly luciferase activities assayed 6 h after treatments are shown. (E) FLAG western blot of parallel 
(heat-treated) cultures from the experiment analyzed under C that compares expression levels of FLAG-LEXA-HSF1 mutant 
S326A and parent FLAG-LEXA-HSF1 one day after transfection. The tubulin signal was used as loading control. The numbers 
below the blots represent a quantitative comparison of the mutant S326A and parent FLAG-LEXA-HSF1 signals in the FLAG 
blot.BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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Table 1: Alanine scan of LEXA-HSF1
Construct Relative luciferase
C S DH SS D
LEXA-HSF1 0.50 0.1 100 13.5
LEXA-HSF1(F) 0.32 0.1 100 6.3
T97A 0.83 0.3 122 5.0
T120A/S121A(F) 0.59 0.1 115 4.7
S123A/T124A 0.65 0.6 95 6.6
S127A 0.50 0.0 84 5.1
S136A/T138A(F) 0.23 0.1 112 11.6
T142A(F) 0.22 0.0 83 11.0
S156A(F) 0.29 0.0 102 6.1
S(174/195/199)A 0.30 0.0 105 8.2
S216A 0.52 0.1 77 10.5
S218A(F) 0.31 0.0 117 9.5
S221A(F) 0.64 0.4 70 8.3
Y225A/S(226/230)A(F) 0.39 0.0 92 5.8
S(237/241/244)A/Y240A 0.54 0.1 126 6.4
Y247A/S(248/249)A(F) 0.72 0.1 127 2.2
S(250/251)A/Y253(F) 1.21 0.3 99 16.6
S(260/261)A 0.84 0.2 119 19.1
S266A/T269A(F) 0.95 0.3 83 11.8
S275A 1.05 0.3 75 5.5
S279A 0.51 0.0 103 24.7
S290A 0.32 0.0 101 13.5
S291A 1.43 0.4 80 4.1
S292A 1.47 0.6 84 3.1
S303A 0.97 0.3 81 13.9
S307A(F) 0.36 0.0 148 33.7
S(303/307)A(F) 1.27 0.5 249 16.9
S314A(F) 0.34 0.0 131 18.3
S(319/320)A/T323A 0.83 0.2 78 10.8
S326A/T328A 2.15 1.0 46 1.9
S333A(F) 0.37 0.0 103 9.3
S338A(F) 0.51 0.1 88 10.1
S344A(F) 0.47 0.1 101 13.4
T346A(F) 0.60 0.1 108 15.0
T349A(F) 0.35 0.1 95 12.6
T(355/357)A(F) 0.34 0.0 129 12.6
S(363/368)A/T(367/369)A(F) 1.05 0.6 92 14.4
S375A 2.13 1.9 73 13.6
S385A(F) 0.57 0.1 121 5.7
S393A 1.38 0.6 83 14.9
T400A/S(403/404)A(F) 0.57 0.2 63 2.9
T411A/S412A(F) 0.57 0.0 85 6.3
S(419/421)A/T423A(F) 0.48 0.0 101 6.7
S428A 0.88 0.1 75 9.6
S(434/435/438)A 1.39 0.1 81 12.9
S444A 1.27 0.2 88 13.2
S(457/458/461)A(F) 0.49 0.1 7 0.3
Y468A/T469A 2.12 1.9 103 16.6
S(480/485)A/T483A 0.47 0.1 80 4.0
S(498/501)A/Y499A 1.08 0.1 80 9.2
T511A/S513A(F) 0.44 0.1 22 1.0
T516A/S518A(F) 0.87 0.1 78 8.1
T527A/S529A 1.14 0.2 91 4.6
S121A 1.73 0.2 106 12.1
S230A 1.64 0.3 101 22.7
S319A 0.60 0.1 105 14.3
S320A 0.36 0.1 91 12.8BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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abilities of mutant and parent factors in cells that either
had been exposed to a 44°C/30 min heat treatment or
had not been heat-treated. It is noted that this heat treat-
ment resulted in only minimal cell death. Results revealed
that most mutants retained the strong heat inducibility of
the respective parent factor (Table 1). Nine mutants (high-
lighted) had an induced activity that was lower than that
of parent factor by more than two average standard devia-
tions (2 × 10.3%). Five of these mutants were only mod-
estly impaired, but four mutants, S326A/T328A, T400A/
S(403/404)A, S(457/458/461)A and T511A/S513A, had
substantially reduced activities. Mutants S326A/T328A
and T511A/S513A were expressed to normal levels. How-
ever, mutant T400A/S(403/404)A accumulated to a
noticeably lower level, and mutant S(457/458/461)A was
cleaved proteolytically (western blot data not shown).
These results suggested the possibility that phosphoryla-
tion of residues 326, 328, 511 and/or 513 played an
important role in activation of HSF1 by heat stress.
Mutants S(303/307)A and S307A were about 150% and
50%, respectively, more active than parent factor in heat-
treated cells (Table 1).
Residues phosphorylated in HSF1 isolated from heat-
treated cells
In a first series of experiments, cultures transfected on the
previous day with expression construct FLAG-HSF1 were
pre-equilibrated with 32PO4 and then heat-treated for 45
min at 44°C. Exogenous HSF1 was immunoprecipitated
using an anti-FLAG resin. In a stained, high-resolution
Tris-Tricine SDS-PAGE gel (Figure 1C), immune-isolated
HSF1 appeared as two sharp bands and a slower migrating
diffuse region that contained the most highly phosphor-
ylated forms (that were also most intensely radiolabeled;
data not shown). Protein from the latter region (see
bracket in Figure 1C) was subjected to trypsin or trypsin/
chymotrypsin digestion. Phosphopeptides were separated
by HPLC, tentatively identified by mass spectrometry
(MALDI-MS) and confirmed by regular and/or radio-
chemical sequencing. In subsequent experiments, pep-
tides from unlabeled, purified FLAG-tagged HSF1
digested with trypsin, trypsin/chymotrypsin, or endopro-
teinases Glu-C or AspN were analyzed by tandem mass
spectrometry (LC/MS/MS). These analyses resulted in an
unambiguous identification of phosphoserines at posi-
tions 121, 230*, 292, 303*, 307*, 314, 319, 326, 344,
363*, 419, and 444 of the HSF1 sequence (Table 2; *pre-
viously reported sites). No phosphorylated Thr or Tyr res-
idues were discovered. This analysis covered >90% of the
HSF1 sequence. No information was obtained about resi-
dues 176–184, 202–206, 225–227, 241–256, 270–284
and 427–432.
Phosphorylation of HSF1 residue Ser326
Based on results from the above-described alanine scan
HSF1 residues 326, 328, 511 and/or 513 were considered
potential sites for regulatory phosphorylation. Of these
residues only Ser326 was actually found phosphorylated in
HSF1 from heat-shocked cells. Not all residues that were
identified as targets of phosphorylation by mass spec-
trometry and/or sequencing had been substituted individ-
ually in the earlier alanine scan. To rule out the possibility
that an effect of substitution of a phosphorylated residue
had somehow been masked or otherwise modulated (in
the case of Ser326) by other substitutions present in the
same mutant, single substitutions were prepared and
examined in the transactivation assay. All substitutions of
phosphorylated serines except for the S326A substitution
displayed heat-induced activities comparable to that of
parent factor (Table 1, bottom). The S326A substitution
was only about 40% as active as the parent factor (35–
55% in individual experiments). To test whether substitu-
tion of Ser326 affected not only heat-induced but also
chemically induced HSF1 activity, the activity of the
S326A mutant was tested in cells exposed to CdCl2. Induc-
tion by CdCl2 was found to be similarly impaired as
induction by heat (Figure 1D). Note that this reduced
activity phenotype was not due to a reduced level of accu-
mulation of the mutant as evidenced by the anti-FLAG
western blot shown in Figure 1E. Nucleotide sequencing
of the entire S326A-coding sequence confirmed that it did
not contain any additional mutation. Furthermore, a sec-
ond copy of mutant S326A obtained in a separate muta-
genesis experiment had a similarly impaired stress-
induced activity as the original copy.
Rapid phosphorylation of HSF1 residue Ser326 during heat 
stress
A phosphopeptide antibody (referred to below as pSer326
antibody) was prepared to specifically monitor
T323A 1.97 0.5 102 17.6
S326A 1.66 0.3 40 8.1
S419A 1.67 0.2 104 17.8
C: not-heated; SD: standard deviation; HS: heat-treated. Transactivation assays were carried out as discussed in Methods and Results. (F) refers to 
the presence of an amino-terminal FLAG tag (see Methods). The activities of FLAG-tagged mutants are expressed relative to the activity of FLAG-
LEXA-HSF1, and those of not-FLAG-tagged mutants to the activity of LEXA-HSF1.
Table 1: Alanine scan of LEXA-HSF1 (Continued)BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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phosphorylation of Ser326. Heat-induced rates of overall
phosphorylation of HSF1 (i.e., phosphorylation of all
available sites), of specific phosphorylation of Ser326 and
of factor oligomerization were compared in the experi-
ment shown in Figure 2 (panels A and B). Cultures were
either not heat-treated or heat-treated at 44°C for 5, 10,
15 or 30 min. HSF1 trimerization was assessed by native
anti-HSF1 blot. As best seen by following the disappear-
ance of the monomeric form, most HSF1 was or was in the
process of becoming oligomeric within 5 min of heat
treatment (Figure 2A). For examining overall and Ser326-
specific phosphorylation, HSF1 was immunoprecipitated
using pSer326 antibody. Immunoprecipitated HSF1 (Fig-
ure 2B, "ip" lanes) and HSF1 in extract ("lysate" lanes)
were detected by anti-HSF1 western blot. To better resolve
different HSF1 species, electrophoresis was continued
until the 50 kDa marker had migrated to the end of the gel
(only the region containing HSF1 forms, i.e. from about
70 kD protein size, is shown in Figure 2B). Results sug-
gested that unstressed cells contained a small amount of
HSF1 that could be immunoprecipitated by the pSer326
antibody ("ip", first lane). Note that, as would have been
expected, the most rapidly migrating immunoprecipitated
HSF1 form was slower than the fastest species present in
extract (compare 0-min "ip" and "lysate" lanes). Upon
heat treatment of the cells, amounts of HSF1 precipitata-
ble from extracts by the pSer326 antibody increased about
3 fold (see quantitation below "ip" lanes). This increase
was essentially complete after only 5 min of heat treat-
ment. Overall phosphorylation as revealed by a shift from
faster- to slower-migrating HSF1 species occurred more
slowly and continued over the entire 30-min course of
heat treatment ("lysate" lanes). A comparable gradual
shift to slower-migrating species was also observed for
pSer326-containing HSF1 species ("ip" lanes). Thus, heat
treatment appeared to result in a substantial increase in
the level of phosphorylation of Ser326. This increase in
phosphorylation occurred about as rapidly as factor oli-
gomerization and preceded phosphorylation of most
other sites.
Heat-induced phosphorylation of Ser326 was confirmed
by a second experiment, in which HSF1 phosphorylated
at Ser326  was detected by anti-pSer326  western blot.
Because of the low avidity of the antibody, HSF1 needed
to be enriched prior to western blot. Large cultures (in 100
mm plates) were transfected with small amounts of
expression construct FLAG-HSF1. One day later, half of
the cultures were heat-treated at 44°C for 30 min, and
tagged HSF1 was immunoprecipitated using an anti-FLAG
Table 2: Residues phosphorylated in HSF1 from heat-treated cells.
Peptide N Phospho-residue Dig.
VEEApSPGRPpSSVDTLLpSPTALIDSILR 4 314, 319, 326 Trp.
VKEEPPpSPPQpSPR 2 303, 307 Trp.
GHTDTEGRPPpSPPPTSTPEK 3 363 Trp.
VVHIEQGGLVKPERDDTEFQHPCFLR 1 (97) Trp.
GHTDTEGRPPpSPPPTSTPEK* 2 363 Trp.
VKEEPPpSPPQpSPR* 2 303, 307 Trp.
QFpSLEHVHGSGPY* 1 230 Trp.
VEEApSPGRPpSSVDTLLpSPTALIDSILR* 3 314, 319, 326 Trp, Chytrp.
VEEASPGRPSSVDTLLpSPTALIDSILR 2 326 Trp, Chytrp.
VEEApSPGRPSSVDTLLpSPTALIDSILR 2 314, 326 Trp, Chytrp.
VKEEPPpSPPQSPR 1 303 Trp, Chytrp.
GHTDTEGRPPpSPPPTSTPEK 2 363 Trp, Chytrp.
KVTpSVSTLKS 1 121 Trp, Chytrp.
PLSSpSPLVR 1 292 Trp, Chytrp.
pSLEHVHGSGPY 1 230 Trp, Chytrp.
DARGHTDTEGRPPpSPPPTSTPEKCLSVACL 2 363 AspN
DERPLSSpSPLVRVK 2 292 AspN
DLFpSPSVTVP 1 419 AspN
DSSLASIQELLpSPQEPPRPPEAENSSP 1 444 AspN
DTLLpSPTALI 1 326 AspN
PASVTALTDARGHTDTEGRPPpSPPPTSTPE 1 363 Glu-C
LLpSPQEPPRPPEAEN 1 444 Glu-C
SEPAPApSVTALTDARGHTDTE 1 344 Glu-C
ApSPGRPSSVDTLLpSPTALID 2 314, 326 Glu-C
LFpSPSVTVPD 1 419 Glu-C
N: Unambiguously identified phosphoresidues are bolded and are preceded by p. Where identification was ambiguous, candidate residues are 
underlined. Dig.: proteinase used for digestion of HSF1. *Radiolabeled peptide. Trp: trypsin; Chytrp: chymotrypsin. For experimental details relating 
to analysis of HSF1 phosphopeptides and identification of phosphorylated residues see Methods.BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
Page 7 of 14
(page number not for citation purposes)
Heat-induced oligomerization and phosphorylation of HSF1 Figure 2
Heat-induced oligomerization and phosphorylation of HSF1. (A) Native anti-HSF1 blot showing heat-induced oli-
gomerization of endogenous HSF1 in response to heat treatment at 44°C (HS) for the times indicated on top of the blot. T: 
HSF1 trimers; D: heterodimers; M: monomers. (B) Parallel cultures to those used in A for an analysis of HSF1 oligomerization 
were employed here for an examination of global or Ser326-specific phosphorylation of endogenous HSF1. The anti-HSF1 west-
ern blot shown reports the distribution of HSF1 forms of different apparent size (reflecting different levels of phosphorylation) 
in extract samples (lysate) or in protein immunoprecipitated from the same extracts by pSer326 antibody (ip). The portion of 
the blot depicted only shows protein signals larger than about 70 kD. (C) Detection of heat-induced phosphorylation of Ser326 
by western blot using anti-pSer326 antibody. Parallel cultures were transfected with small amounts of FLAG-HSF1. One day 
later, the cultures were either left untreated (C) or were heat-treated for 30 min at 44°C (HS) and were processed for west-
ern blot immediately following the heat treatment. The anti-pSer326 blot reports on induction of Ser326 phosphorylation by 
heat, and the parallel anti-FLAG blot shows that similar amounts of FLAG-HSF1 were compared in the anti-pSer326 blot. Data 
from densitometry are shown below the blots. Brackets shown on the side of blots indicate lengths of regions scanned. In A, 
the monomer signal was quantitated.
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Comparative analyses in HSF1-negative mouse embryo fibroblasts Figure 3
Comparative analyses in HSF1-negative mouse embryo fibroblasts. (A) Comparison of DNA-binding abilities of 
HSF1 and HSF1 mutant S326A. An electrophoretic mobility shift assay was carried out using an HSE DNA probe and extracts 
from heat-treated or not-heat-treated cells that had been transfected one day earlier with the constructs indicated on top of 
the gel. An anti-HSF1 western blot of the same samples reporting on the relative levels of expression of HSF1 forms from the 
different constructs is shown below the gel. HSF1/HSE: HSF1-DNA complex; NS: nonspecific signal, serving as a loading con-
trol for the group of samples from not-heated cells, and, independently, for the group of samples from heat-treated cells; HS: 
heat-treated for 30 min at 43°C; C: not heat-treated. (B) Heat-induced transactivation of endogenous hsp70 gene(s) in cells 
transfected with small amounts of the constructs indicated above the blots and with luciferase reporters HSP70-fLUC and pRL-
CMV. One day after transfection, cultures were either left untreated (C) or were heat-treated for 30 min at 43°C (HS). 
Extracts were prepared after 6 h of further incubation at 37°C and were used for western blots. The top blot was probed with 
an antibody recognizing HSP70, whereas the bottom blot was probed with HSF1 antibody. The bottom blot demonstrates that 
mutant and wildtype HSF1 forms accumulated to similar levels. Note the presence of a weak nonspecific signal present in all 
lanes that happened to co-migrate with the transfected HSF1 forms. (C) Quantitative comparisons of data of B. (D) Relative 
luciferase reporter activities in the same extracts that were analyzed for HSP70 in B. Representative results from one of sev-
eral independent experiments are shown in this Figure.
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resin. Immune-isolated material was then analyzed by
western blot using pSer326 and FLAG antibodies (Figure
2C). Recovery of FLAG-HSF1 from heat-treated and
untreated cells was comparable (anti-FLAG blot on top).
A substantially larger fraction (2.5 fold) of factor from
heat-treated cells than from not-heat-treated cells reacted
with the pSer326 antibody.
Phosphorylation of Ser326 specifically enhances HSF1 
transactivation competence
To examine the effects of substitution of Ser326 in an oth-
erwise wildtype HSF1 background, use was made of an
HSF1-negative mouse cell line prepared previously by
McMillan et al. [31]. Analyses were carried out one day
after transfection of expression constructs for HSF1, sub-
stitution mutant S326A (in wildtype HSF1 not LEXA-
HSF1 background) and control protein β -galactosidase.
First, it was examined whether phosphorylation of Ser326
affected the first step of HSF1 activation, which step
involves acquisition of HSE DNA-binding activity and
nuclear localization. Electrophoretic mobility shift assay
revealed that HSE DNA-binding activities of wildtype
HSF1 and mutant S326A were heat-induced to similar lev-
els (Figure 3A). Nuclear localization was assayed by
standard fractionation of cell extracts and anti-HSF1 west-
ern blot. Comparable amounts of wildtype HSF1 and
mutant S326A were present in the nuclear fraction of heat-
treated cells (data not shown). Thus, phosphorylation of
Ser326 did not affect the first step of HSF1 activation. To
probe the second activation step, i.e., acquisition of trans-
activation competence, HSF1-negative cells were co-trans-
fected with the above expression constructs and with
reporter constructs HSP70-fLUC and rLUC. Cultures
either were left untreated or were heat-treated at 43°C for
30 min and further incubated for 6 hours. Transactivation
competence was estimated by western blot of endogenous
HSP70 (Figure 3, panels B and C) and by luciferase assay
(Figure 3D). Heat-induced expression of endogenous
HSP70 was reduced by 80% in the cells expressing the
S326A mutant of HSF1 when compared to the cells
expressing wildtype HSF1. The transfected luciferase
reporter was reduced by 50%. The greater effect on HSP70
expression is likely explained by the difference in RNA/
protein stability between HSP70 and luciferase.
Discussion
The present study attempted for the first time to examine
phosphorylation of HSF1 in cells exposed to a stress in a
comprehensive fashion. Although HSF/HSF1 is activated
in cells exposed to various types of stressful events, in the
interest of being able to complete a thorough analysis, we
decided to focus on phosphorylation of HSF1 in cells
responding to a single type of stress, i.e., a heat stress. Our
study identified twelve serine residues in human HSF1
that are phosphorylated in heat-stressed cells. Eight of
these residues represent phosphorylation sites that were
not previously known, i.e., Ser121, Ser292, Ser314, Ser319,
Ser326, Ser344, Ser419, and Ser444. Phosphorylation of all
residues previously found to be phosphorylated in vivo,
i.e., Ser230, Ser303, Ser307 and Ser363, was confirmed. No
phosphorylation of Thr142 or any other Thr or Tyr residue
was observed.
Because the importance of the various phosphorylation
events for the activation of human HSF1 could not be pre-
dicted, an effort was made to ensure that the basic trans-
activation assay used in the present study was capable of
reporting even relatively minor impairments in the activ-
ity of HSF1 mutants as well as examined the exogenous
HSF1 forms under conditions that differed as little as pos-
sible from those encountered by endogenous factor.
Although HSF1-deficient mouse cells were available and
were used in later experiments, our initial goal was to
identify mutants of human HSF1 that were functionally
deficient in human cells. Therefore, mutants were
prepared in the LEXA-HSF1 background, allowing us to
test effects of mutations in cells containing endogenous
HSF1. Because hyperphosphorylation was expected to
affect HSF1 transcriptional competence rather than HSE
DNA-binding ability, use of an HSF1 form identical to
HSF1 except for a substituted DNA-binding domain
appeared justified. For obvious reasons, an HSF1 mutant
with an impaired activity was not available when assay
conditions needed to be established. In the absence of
such a mutant, assay conditions were defined, under
which reporter activity increased proportionally with
amounts of LEXA-HSF1 expression construct transfected.
Under the chosen conditions, exogenous HSF1 (i.e.,
LEXA-HSF1) was expressed at a comparable level as
endogenous HSF1. Hence, these conditions also satisfied
our second criterion that was to assay exogenous HSF1 in
an intracellular situation that closely resembled that
encountered by endogenous HSF1. The importance of the
latter criterion is exemplified by the previous observation
that substantially overexpressed exogenous HSF1 is
trimeric and DNA binding in the absence of a stress,
whereas endogenous HSF1 is not trimeric and DNA bind-
ing under the same conditions [7]. In the transactivation
assays used in the present study, exogenous HSF1 did not
specifically bind DNA in the absence of a stress.
The above-discussed differences between the transactiva-
tion assay used in the present study and assays employed
in earlier studies provide a ready explanation for the
observed differences in phenotypes of mutants S(303/
307)A and S307A. The latter substitutions (also in LEXA-
HSF1 background) had been examined in a previous
study by our laboratory and were found to be active in the
absence of a stress [28] (see also [9,23,25]). In this earlier
study, HSF1 forms were substantially overexpressed,BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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resulting in accumulation of homotrimeric factors in the
absence of a stress. Therefore, the experiments were only
capable of assessing effects of mutations on HSF1
transcriptional competence. When examined using the
assay of the present study, in which assay oligomerization
of exogenous HSF1 forms is regulated, the Ser307 and
Ser303/Ser307 substitutions could be expected to be inactive
in the absence of a stress, provided that the mutations
only affected HSF1 transactivation competence and not
also oligomerization. As shown in Table 1, this expected
result was observed. In heat-stressed cells, however, the
Ser307 and Ser303/Ser307 substitutions exceeded the activity
of the parent factor. This finding is consistent with a role
of phosphorylation at Ser303 and Ser307 in down-modula-
tion of HSF1 activity during a heat stress or, more likely,
during recovery from the stress. Such a role has been pro-
posed previously by others (e.g., [23,27,32]). Also com-
patible with this hypothesis is that, in a tryptic digest of
HSF1 isolated from cells pulse-labeled with 32PO4 during
a 44°C/45 min heat treatment, peptide 297–309 was
among the most intensely radiolabeled peptides (not
shown). This finding implied that phosphorylation of
Ser303 and/or Ser307 occurred during heat treatment. Hie-
takangas et al. recently confirmed that Ser303 is inducibly
phosphorylated by western blot experiments using a
phosphopeptide antibody recognizing pSer303 [33]. As
Ser303 phosphorylation may require prior phosphoryla-
tion of Ser307 [23], phosphorylation of Ser307 is likely also
heat-inducible.
The present study identified HSF1 residue Ser326 as a dom-
inant target of regulatory phosphorylation during activa-
tion of the factor by a heat stress. Luciferase reporter assays
indicated that phosphorylation of Ser326 causes the heat-
induced activity of HSF1 to at least double. The transacti-
vation assays in which endogenous HSP70 was used as the
endpoint revealed that this enhancement of HSF1 activity
translates into a fivefold increase in accumulation of
HSP70. While our study did not address this issue, it
seems likely that the observed five-fold enhancement of
HSP70 expression resulting from phosphorylation of
Ser326 is physiologically important. A previous study dem-
onstrated that a five to eight fold impairment in heat-
induced HSP70 expression led to substantially dimin-
ished thermotolerance of the affected mouse embryo
fibroblast cells [34]. Phosphorylation of Ser326  also
appears to significantly contribute to HSF1 activity
induced in cells stressed by exposure to CdCl2.
Our analyses suggested that, individually, phosphoryla-
tion of none of the other residues identified as being
phosphorylated in heat-treated cells significantly contrib-
utes to HSF1 activity. The possibility was considered that
phosphorylation of several of these residues may be
required for producing a clearly detectable effect.
Although this possibility was not examined exhaustively,
several combinations of substitutions including or exclud-
ing the S326A substitution were tested by transactivation
assay (data not shown). These experiments failed to
uncover evidence for a functional effect of phosphoryla-
tion on residues other than Ser326. It is puzzling that HSF1
is phosphorylated on a number of residues (e.g., Ser121,
Ser230, Ser292, Ser314, Ser319, Ser344, Ser419, and Ser444)
whose phosphorylation does not appear to affect factor
activity. The possibility cannot be formally ruled out that
phosphorylation of some of these residues may reflect
artifacts due to differences in phosphorylation of exoge-
nous and endogenous HSF1. A more reasonable explana-
tion may be that this phosphorylation may be relevant
under conditions not tested in the present study. Such
conditions may include different types of stresses or dif-
ferent levels of stresses used to activate HSF1. They may
even relate to differences in the transactivation assays used
that may result in preferential assessment of different fac-
ets of HSF1 activation. This latter explanation may apply
to phosphorylation of Ser230 that was previously reported
to contribute to activation of HSF1 by heat stress [19].
Another likely possibility is suggested by the fact that
HSF1 not only transactivates HSP genes but also
participates in the regulation of several important signal-
ing pathways (e.g., [35-38]). Phosphorylation of Ser resi-
dues that appears gratuitous with respect to regulation of
HSP expression may affect interactions of HSF1 with com-
ponents of these other pathways and alter their activity.
In agreement with earlier work, heat stress induced rapid
trimerization of HSF1. The substantial enhancement of
phosphorylation of Ser326 that was induced by heat stress
occurred within a similar time frame. This rapid rate of
phosphorylation of Ser326 was commensurate with what
was expected for a phosphorylation event that was critical
for heat stress activation of HSF1. Most other phosphor-
ylation events that could be monitored by their effect on
gel mobility occurred more slowly. Hence, it was possible
that some of these later events required prior phosphor-
ylation of Ser326. However, that at least some of this phos-
phorylation occurred independent of Ser326
phosphorylation was suggested by the observation of a
heat-induced SDS-PAGE mobility shift for mutant S326A
(data not shown).
The present study provides evidence that phosphorylation
of Ser326 stimulates the transcription-enhancing activity of
HSF1 but not its DNA-binding activity. How this phos-
phorylation results in increased transcriptional compe-
tence of HSF1 remains to be elucidated. The observation
that substitution of Ser326 with neither Asp nor Glu repro-
duced the effect of phosphorylation on factor activity
(data not shown) suggested that the mechanism is not
based on simple charge repulsion. Perhaps,BMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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phosphorylation of Ser326 induces a local conformational
change that affects binding of a chaperone complex or
another regulatory protein to the nearby regulatory
domain that is known to be involved in repression of tran-
scriptional competence [6]. Alternatively, pSer326 may be
a critical aspect of a binding site for an unknown co-acti-
vator. Identification of the protein kinase that phosphor-
ylates Ser326 in heat-stressed cells would be helpful for
determining whether the level of phosphorylation of the
residue is actively regulated and, if this were the case, by
what stress-induced mechanism. Unfortunately, a search
of the sequence within which Ser326 is embedded for pro-
tein kinase sites using the NetPhosp program [39] did not
provide any useful information about candidate protein
kinases.
Conclusion
The present article is concerned with regulation of human
HSF1, which is a key factor mediating the transcriptional
response of human cells to physical and chemical stresses
and a coregulator of other important signaling pathways
(e.g.. [35-38]). HSF1 has even been discovered to regulate
aging and age-related disease [40,41]. To arrive at a better
description of the mechanisms that enable cells to
respond to various stresses by transiently upregulating
HSP gene expression, it will be important to learn about
the extent to which phosphorylation of HSF1 modulates
these responses as well as to discover how phosphoryla-
tion/dephosphorylation of HSF1 itself is regulated by
stresses. Furthermore, it can be expected that a thorough
understanding of regulatory phosphorylation of HSF1
will advance our knowledge about what controls the
interactions of this factor with other pathways as well as
likely will, through the eventual identification of regu-
lated protein kinases and phosphatases involved in HSF1
phosphorylation and dephosphorylation, lead to the
identification of new connections with additional regula-
tory systems. The present study represents an initial con-
tribution towards these larger goals. Our systematic
analysis of HSF1 phosphorylation in heat-stressed cells
identified twelve phosphorylated Ser residues, of which
eight were not previously known. Mutagenesis and func-
tional experiments revealed that newly identified
phosphoSer326 plays an important role in heat activation
of HSF1 transcriptional activity as evidenced by the fact
that substitution of this residue reduced HSP70 accumu-
lation several fold. Phenotypes for substitutions of Ser303
and Ser307 were observed that are consistent with the pre-
viously proposed function of phosphorylation of these
residues in HSF1 deactivation. Although no evidence for
functional roles of other phosphoserines could be
obtained in this study, knowledge of the identity of most
or all residues phosphorylated in heat-activated HSF1
should greatly facilitate further directed experiments to
test the potential importance of their phosphorylation in
the various processes and interactions in which HSF1 is
known to participate. It cannot be excluded that through
the use of different transactivation assays functions of the
latter phosphoresidues in heat regulation of HSF1 activity
may be discovered that escaped detection in this study.
Methods
Antibodies
PhosphoSer326-specific rabbit polyclonal antibody was
raised against peptide CSVDTLLpSTAL. The antiserum was
positively and negatively affinity-purified on immobi-
lized phosphorylated and unphosphorylated peptide. For
immunoprecipitations, purified antibody was cross-
linked to a resin using the Seize Primary Immunoprecipi-
tation Kit (Pierce). HSF1 antiserum was from StressGen
Biotechnologies; FLAG antibody M5, FLAG resin M2 and
tubulin antibody were from Sigma; HSP70 antibody 4G4
was from Affinity Bioreagents. Mouse monoclonal anti-
body 4G4, which antibody was raised against human
Hsp70, also recognizes mouse Hsp70. Antibody signals
were detected by chemifluorescence and were quantitated
on a Molecular Dynamics Storm system.
Cell culture
Hela-CAT cells [42] were maintained at 37°C and 5%
CO2 in DMEM containing 10% fetal bovine serum, 100U/
ml penicillin and 100 µg/ml streptomycin. HSF1-negative
mouse embryo fibroblasts were grown in supplemented
DMEM as described by McMillan et al. [31].
Expression constructs and site-directed mutagenesis
Sequences coding for complete (human) HSF1 (residues
1–529), LEXA-HSF1 (containing residues 1–87 of LEXA
and residues 79–529 of human HSF1) and amino-termi-
nally FLAG-tagged derivatives were subcloned into
pcDNA3.1(+) (Invitrogen), placing the sequences under
the control of a CMV promoter [7]. These constructs were
named HSF1, LEXA-HSF1, FLAG-HSF1 and FLAG-LEXA-
HSF1, respectively. For the alanine scan, LEXA-HSF1 and
FLAG-LEXA-HSF1, were used as templates for Quik-
ChangeR site-directed mutagenesis (Stratagene Instruction
Manual). Complementary primer pairs replaced single or
multiple Ser, Thr or Tyr codons with Ala codons. Potential
mutant genes were characterized by restriction analysis,
expression in a rabbit reticulocyte lysate-based transcrip-
tion and translation system (T7 Quick TNT system,
Promega) and nucleotide sequence analysis. Several
mutations were also introduced into construct HSF1 using
the same approach. The β -galactosidase expression con-
struct (B-GAL) used was pcDNA3.1/His/ LacZ
(Invitrogen).
Transactivation assay
Reporter construct LEXA-fLUC was described previously
[42]. Reporter gene HSP70-fLUC was obtained byBMC Biochemistry 2005, 6:4 http://www.biomedcentral.com/1471-2091/6/4
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subcloning promoter and RNA leader sequences of the
human HSP70B gene into a plasmid containing a firefly
luciferase gene. Constructs containing a constitutively
expressed Renilla luciferase gene (pRL-TK, pRL-CMV) were
obtained from Promega. Cultures in 96-well plates were
transfected using a rapid transfection protocol for Lipo-
fectamine 2000 (Gibco). Typically, each well received
0.75–1.0 µl of Lipofectamine 2000 in 25 µl Opti-MEM
and a DNA master mixture (88.25 ng) in 25 µl Opti-MEM
consisting of 80 ng of LEXA-fLUC or HSP70-fLUC, 0.25 ng
of pRL-Tk or 0.1 ng of pRL-CMV, 0.1–0.5 ng of LEXA-
HSF1 or HSF1 (or a mutant) and 7.5–8.05 ng of B-GAL.
80,000 cells in 100 µl DMEM were added subsequently.
Typically, transfections were carried out in triplicate.
Transfected cells were incubated for 16–20 hours, heat-
treated at 44°C for 30 min (unless indicated otherwise) or
not heat-treated and harvested 6–7 hours later. The length
of the period between heat treatment and cell harvest was
optimized for expression of firefly luciferase and recovery
of Renilla luciferase activity. Luciferase activity was meas-
ured using the Dual Luciferase Kit (Promega) and a Stratec
plate luminometer. Typically, luciferase activity assays
were performed in triplicate.
Electrophoretic mobility shift assay
Cells were transfected in 100 mm-dishes with Lipo-
fectamine PLUS, 25 ng of HSF1 or mutant HSF1 expres-
sion construct and 2.975 µg B-GAL according to the
manufacturer's instructions, incubated for 24 hours and
then either heat-treated or left untreated. PBS-washed cells
were resuspended in buffer C (20 mM Hepes, pH7.9, 0.42
M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithioth-
reitol, "Complete" Protease Inhibitor Cocktail (Roche),
25% glycerol). Extracts were prepared by three cycles of
quick-freezing and thawing, and clarification by centrifu-
gation. The same protocol was also employed for
preparing extracts used for native gel electrophoresis.
Extracts were either used immediately or were stored at -
70°C. Electrophoretic mobility shift assays were carried
out essentially as described before [7]. Signals were
detected and quantified using a Molecular Dynamics
PhosphorImager.
Subcellular fractionation
Cells were transfected as described under the previous sec-
tion. Fractionation was performed using NE-PER Nuclear
and Cytoplasmic Extraction Reagents from Pierce accord-
ing to the manufacturer's protocol. Correct operation of
the protocol was verified by following endogenous HSF1
whose localization had been determined previously.
Analysis of HSF1 phosphopeptides and identification of 
phosphorylated residues
9.0 × 106 Hela-CAT cells in 150-mm dishes were trans-
fected with 32 µg of FLAG-HSF1 expression construct. For
experiments involving analysis of radiolabeled phos-
phopeptides, 20 hours after transfection each culture was
washed once with 25 ml phosphate-free DMEM contain-
ing 5% FCS and was incubated for 1 hour in the same
medium. Medium was replaced by fresh medium further
containing 2 mCi of 32P-orthophosphate (NEX011,
NEN), and cells were incubated for 3 hours at 37°C. After
heat treatment for 45 min at 44°C, cells were washed with
ice-cold PBS and lysed by incubation for 15 min at room
temperature in 3 ml Mper buffer (Pierce) supplemented
with 0.5 mM NaV3, 5 mM NaF, 150 mM NaCl, 1 µM
ocadaic acid and "Complete" Protease Inhibitor Cocktail
(Roche). After removal of debris, extract was incubated
overnight at 4°C with 80 µl of FLAG M2 resin. Resin was
washed extensively with Mper buffer containing 150 mM
NaCl and Mper buffer alone, and FLAG-HSF1 was eluted
with 120 µl of 6X SDS-PAGE sample buffer. Subsequent to
electrophoresis on a Tris-Tricine high-resolution SDS-
PAGE gel [43], FLAG-HSF1 was Coomassie-stained, and
gel pieces containing the most highly phosphorylated
species were processed by the Keck Foundation Biotech-
nology Resource Laboratory at Yale (Kenneth Williams)
for proteolytic digestion, mass spectrometric analysis, and
radiochemical and normal peptide sequencing. In other
experiments, unlabeled, purified FLAG-HSF1 was pre-
pared using a similar protocol. Sequence analysis of these
preparations was performed at the Harvard Microchemis-
try Facility using microcapillary reverse-phase HPLC
nano-electrospray tandem mass spectrometry on a Finni-
gan LCQ DECA quadrupole ion trap mass spectrometer.
Other methods
For most immunoprecipitation and HSF1 expression
experiments, cells were lysed in MPer-buffer supple-
mented with 150 mM NaCl and "Complete" Protease
Inhibitor Cocktail from Roche. Protein concentrations in
extracts were measured using a Bradford assay (Protein
Assay reagent from Bio-Rad Laboratories). Results were
used to adjust protein concentrations in extracts to be
compared.
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